TerrAscend Corp. (OTCMKTS:TSNDF – Free Report) – Investment analysts at Atb Cap Markets lowered their FY2025 earnings per share (EPS) estimates for shares of TerrAscend in a note issued to investors on Monday, December 9th. Atb Cap Markets analyst F. Gomes now expects that the company will earn ($0.13) per share for the year, down from their prior estimate of ($0.09). Atb Cap Markets currently has a “Hold” rating on the stock. The consensus estimate for TerrAscend’s current full-year earnings is ($0.14) per share.
TerrAscend Stock Down 1.4 %
OTCMKTS:TSNDF opened at $0.75 on Wednesday. The company has a current ratio of 1.35, a quick ratio of 0.69 and a debt-to-equity ratio of 0.81. The company has a fifty day moving average price of $0.99 and a 200 day moving average price of $1.23. TerrAscend has a one year low of $0.66 and a one year high of $2.45.
About TerrAscend
TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.
Read More
- Five stocks we like better than TerrAscend
- How to Most Effectively Use the MarketBeat Earnings Screener
- 4 Stocks Planning to Return Capital With Hefty Buyback Programs
- The Risks of Owning Bonds
- Overblown Holiday Worries? 3 Stocks Set for a Surprise Comeback
- Compound Interest and Why It Matters When Investing
- UiPath: A Golden Opportunity in AI-Driven Workflow Automation
Receive News & Ratings for TerrAscend Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TerrAscend and related companies with MarketBeat.com's FREE daily email newsletter.
